a developer of pharmaceutical products
Industry Biotechnology
A.I.dvisor tells us that NVO and NONOF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVO and NONOF's prices will move in lockstep.
Ticker / NAME | Correlation To NVO | 1D Price Change % | ||
---|---|---|---|---|
NVO | 100% | -1.49% | ||
NONOF - NVO | 30% Poorly correlated | +0.93% | ||
HOOK - NVO | 28% Poorly correlated | -8.19% | ||
VRTX - NVO | 28% Poorly correlated | -2.15% | ||
SCPX - NVO | 28% Poorly correlated | -0.27% | ||
IMRN - NVO | 28% Poorly correlated | -2.53% | ||
More |
Ticker / NAME | Correlation To NVO | 1D Price Change % |
---|---|---|
NVO | 100% | -1.49% |
pharmaceuticals theme (159 stocks) | 33% Loosely correlated | -1.90% |
europe theme (179 stocks) | 29% Poorly correlated | -0.09% |
caring for seniors theme (20 stocks) | 24% Poorly correlated | -1.62% |
seniors care theme (20 stocks) | 24% Poorly correlated | -1.62% |